Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Journey Medical (DERM) Interest Expenses (2020 - 2025)

Historic Interest Expenses for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $937000.0.

  • Journey Medical's Interest Expenses rose 2361.48% to $937000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year increase of 8996.3%. This contributed to the annual value of $2.7 million for FY2024, which is 5901.06% up from last year.
  • Journey Medical's Interest Expenses amounted to $937000.0 in Q3 2025, which was up 2361.48% from $937000.0 recorded in Q2 2025.
  • Over the past 5 years, Journey Medical's Interest Expenses peaked at $4.1 million during Q4 2021, and registered a low of $24000.0 during Q4 2023.
  • For the 5-year period, Journey Medical's Interest Expenses averaged around $853473.7, with its median value being $650000.0 (2023).
  • Per our database at Business Quant, Journey Medical's Interest Expenses crashed by 9611.02% in 2023 and then skyrocketed by 336250.0% in 2024.
  • Quarter analysis of 5 years shows Journey Medical's Interest Expenses stood at $4.1 million in 2021, then plummeted by 84.94% to $617000.0 in 2022, then plummeted by 96.11% to $24000.0 in 2023, then surged by 3362.5% to $831000.0 in 2024, then grew by 12.76% to $937000.0 in 2025.
  • Its Interest Expenses stands at $937000.0 for Q3 2025, versus $937000.0 for Q2 2025 and $891000.0 for Q1 2025.